The onset of the coronavirus disease 2019 (COVID-19) brought about intensive research on the biological characteristics of the pathogen responsible, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The immune response mediated by neutralizing antibodies, elicited by the virus or…
Read More
UK SARS-CoV-2 variant 40% more transmissible than previous strains
Researchers in Japan have estimated that the B.1.1.7 variant strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that recently emerged in England is 40% more transmissible than strains previously circulating in the country. The SARS-CoV-2 virus is the agent…
Read More
White-tailed deer susceptible to SARS-CoV-2, finds study
White-tailed deer have been observed to be susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). They can also transmit the virus both through direct and indirect contact to one another, researchers find. The research paper is available to be…
Read More
Impact of type I interferon (IFN) autoantibodies in critical COVID-19
The emergence and rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has triggered the coronavirus disease 2019 (COVID-19) pandemic. To date, over 118 million cases have been confirmed, and over 2.6 million have lost their lives. The sheer…
Read More
Ultraviolet light therapy reduces viral load in critically ill COVID-19 patients
A team of scientists from the United States has recently evaluated the safety and efficacy profiles of ultraviolet-A (UVA) light applied via an endotracheal tube to critically ill coronavirus disease 2019 (COVID-19) patients. The findings reveal that specific and monitored…
Read More
How do viruses evolve in bats?
Bats have played a crucial epidemiological role in the evolution of many viruses and house many coronaviruses. Until 2002, coronaviruses had been known to cause mild respiratory ailments in human beings. However, this notion changed in the same year when…
Read More
Continued vigilance needed as COVID lockdown is relaxed in England, warn researchers
Researchers have reported findings from round nine of the REal-time Assessment of Community Transmission Study (REACT-1) that estimates community prevalence of infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in England. The SARS-CoV-2 virus is the agent responsible for…
Read More
Novel host-viral-microbiome interactions during COVID-19 may determine outcome
The current pandemic of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been spreading rapidly for over a year. Though primarily a respiratory illness, its manifestations are often protean and may be life-threatening….
Read More
Concerning mutation in New York SARS-CoV-2 should be monitored, warn researchers
Researchers at the New York State Department of Health in the United States have said concerning mutations within the B.1.526 lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has recently become prevalent in New York State warrant further…
Read More
Early tracheostomy could reduce recovery time in critical COVID-19, say researchers
The ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is primarily a severe pulmonary disease that can be fatal in a significant minority of cases. It leads to respiratory insufficiency in a…
Read More